QCR6 Antibody

What is QCR6 and why is it important in mitochondrial research?

QCR6 is a subunit of mitochondrial ubiquinol-cytochrome c oxidoreductase (also called Complex III), which plays a crucial role in the electron transport chain. In Arabidopsis mitochondria, for example, Complex III contains 10 subunits with QCR6 (AT1G15120/AT2G01090) being one of them . QCR6 has structural similarity to twin CX9C proteins, featuring two canonical α-helices joined by a single disulfide bond in a distinctive 'hinge' shape . The importance of QCR6 in mitochondrial research stems from its critical role in preserving the heme environment of cytochrome c1 inside Complex III and promoting interaction with cytochrome c . Studies have shown that cells lacking QCR6 exhibit blocked maturation of cytochrome c1, attenuated Complex III catalytic activity, and impaired growth . Therefore, antibodies against QCR6 provide valuable tools for investigating mitochondrial function, electron transport mechanisms, and respiratory chain assembly.

What sample preparation methods are optimal for QCR6 antibody applications?

For optimal results with QCR6 antibodies, proper sample preparation is essential:

• Mitochondrial Isolation: Use differential centrifugation with sucrose gradient purification to obtain intact mitochondria.

• Protein Extraction:

  • For Western blotting: Use RIPA buffer supplemented with protease inhibitors

  • For immunoprecipitation: Milder detergents like 1% digitonin or 0.5% DDM better preserve protein-protein interactions

• Sample Storage: Store protein extracts at -80°C in single-use aliquots to avoid freeze-thaw cycles that can degrade epitopes .

• Fixation for Microscopy:

  • For immunofluorescence: 4% paraformaldehyde for 15 minutes

  • For electron microscopy: Glutaraldehyde/paraformaldehyde mixture followed by careful dehydration

When working with plant samples such as Arabidopsis thaliana, additional cell wall disruption steps may be necessary to access mitochondrial proteins effectively .

How should QCR6 antibodies be stored and handled to maintain activity?

To maintain optimal QCR6 antibody activity, observe these storage and handling recommendations:

• Store lyophilized antibody preparations according to manufacturer specifications, typically at -20°C or -80°C .

• Use a manual defrost freezer to prevent damage from temperature fluctuations that occur in auto-defrost units .

• Avoid repeated freeze-thaw cycles by aliquoting the reconstituted antibody into single-use volumes .

• Upon receiving shipped antibodies (typically at 4°C), immediately transfer to appropriate long-term storage conditions .

• When working with the antibody:

  • Thaw aliquots on ice

  • Centrifuge briefly before opening tubes to collect all material

  • Use sterile technique to prevent contamination

  • Return unused portions to storage promptly

• For diluted working solutions, add carrier proteins (0.1-1% BSA) to prevent adsorption to tube walls and maintain stability.

How can QCR6 antibodies elucidate the role of QCR6 in cytochrome c transport?

QCR6 antibodies can be strategically employed to investigate the protein's role in facilitating cytochrome c transport between respiratory complexes:

• Co-immunoprecipitation studies: QCR6 antibodies can capture protein complexes to identify transient interactions between QCR6 and cytochrome c during electron transport. This approach has revealed that QCR6 directly contributes to the mechanism of cytochrome c turnover despite not being required for supercomplex formation .

• Proximity labeling techniques: Combining QCR6 antibodies with BioID or APEX2 proximity labeling can map the dynamic protein interaction network around QCR6 during active electron transport.

• Conformational studies: Research has shown that the N-terminal region of QCR6 is conformationally transient with no reported structure in high-resolution models . Epitope-specific antibodies targeting different regions can be used to track conformational changes during the catalytic cycle.

• Supercomplex analysis: Computational and experimental evidence indicates that QCR6-assisted transport of cytochrome c between donor and acceptor complexes may be ubiquitous to electron transport chains across species . QCR6 antibodies can help validate these models through immunolocalization in supercomplex preparations.

The experimental data demonstrates that deletion of QCR6 (ΔQCR6) reduces the CIII-CIV recognition surface for cytochrome c from 1.1 cyt. c/Ų in wild-type to 0.7 cyt. c/Ų , providing quantitative evidence of QCR6's role in organizing the electron transport pathway.

What techniques can investigate QCR6-lipid interactions in the mitochondrial membrane?

Recent research indicates that QCR6 interacts with membrane lipids, particularly cardiolipin, which influences cytochrome c transport. The following techniques employ QCR6 antibodies to investigate these interactions:

• Co-sedimentation assays with liposomes: Using QCR6 antibodies to detect protein binding to synthetic liposomes of defined composition.

• Fluorescence resonance energy transfer (FRET): Between labeled QCR6 antibody fragments and fluorescent lipid analogs to measure proximity and interaction dynamics.

• Immunogold electron microscopy: QCR6 antibodies conjugated to gold nanoparticles can visualize the spatial relationship between QCR6 and specific membrane domains.

• Lipid-protein overlay assays: Detecting QCR6 binding to immobilized lipids using specific antibodies as detection reagents.

Research has revealed that specific arginine residues (e.g., Arg104) in QCR6 interact with cardiolipin headgroups . This interaction is functionally significant as simulations show that electrostatic coupling between QCR6 and anionic lipids reduces the energetic cost of cytochrome c transport across the supercomplex by 25-30 kcal/mol . These findings suggest that membrane lipids don't merely provide structural support but actively participate in the electron transport mechanism through specific interactions with QCR6.

How do QCR6 antibodies contribute to understanding evolutionary conservation of respiratory complexes?

QCR6 antibodies provide valuable tools for comparative studies across species to understand the evolutionary conservation of respiratory complex structure and function:

• Cross-reactivity profiling: Testing QCR6 antibodies against homologs from different species reveals conserved epitopes, providing insight into structural conservation. Sequence alignment analysis shows conservation of functional residues like Arg104 across diverse species despite variations in the length of the hinged region .

• Epitope mapping: Using domain-specific QCR6 antibodies to identify which regions are more conserved across evolutionary distance.

• Functional conservation studies: Combining QCR6 antibody detection with activity assays to correlate structural conservation with functional roles.

• Supercomplex organization: Comparing supercomplex architecture across species using QCR6 antibodies as markers for complex assembly and interaction.

Evolutionary insights suggest that QCR6-assisted transport of cytochrome c between the donor and acceptor complexes may be a fundamental mechanism conserved throughout the electron transport chain across species . This conservation highlights the critical nature of QCR6's role in mitochondrial function throughout evolutionary history.

What are the critical controls for validating QCR6 antibody specificity?

To ensure research reliability, proper validation of QCR6 antibody specificity is essential:

• Positive controls:

  • Recombinant QCR6 protein

  • Tissue/cells known to express high levels of QCR6

  • Overexpression systems (e.g., CHO/mCCR6 cells as used for other receptor antibodies)

• Negative controls:

  • QCR6 knockout/knockdown samples

  • Pre-immune serum for polyclonal antibodies

  • Isotype control for monoclonal antibodies

  • Peptide competition assays

• Specificity verification methods:

  • Western blot should show a single band at the expected molecular weight

  • Mass spectrometry confirmation of immunoprecipitated proteins

  • RNA-protein correlation (compare antibody signal with mRNA expression)

• Cross-reactivity assessment:

  • Testing against closely related proteins

  • Examination in multiple species if claiming cross-reactivity

Proper validation should be documented with quantitative measures. For instance, high-affinity antibodies should demonstrate dissociation constants (KD) in the nanomolar range, similar to the C6Mab-13 antibody developed for CCR6 with a KD of 2.8 × 10⁻⁹ M .

What troubleshooting steps should be taken when QCR6 antibodies produce unexpected results?

When working with QCR6 antibodies, researchers may encounter various technical challenges. Here's a systematic approach to troubleshooting:

• No signal or weak signal:

  • Verify protein expression (RNA level, alternative antibody)

  • Increase antibody concentration

  • Extend incubation time

  • Check epitope accessibility (try different extraction methods)

  • Verify storage conditions haven't compromised antibody activity

  • Try different detection systems

• Multiple bands or non-specific binding:

  • Optimize blocking conditions (increase BSA/milk concentration)

  • Reduce antibody concentration

  • Increase washing stringency

  • Try different extraction buffers to reduce conformational variants

  • Consider post-translational modifications or degradation products

• Inconsistent results between experiments:

  • Standardize protein loading and transfer efficiency

  • Use internal loading controls

  • Prepare fresh reagents

  • Control temperature during incubations

  • Document lot-to-lot variations in antibodies

• Differing results between techniques:

  • Recognize that fixation for immunohistochemistry may alter epitopes

  • Native vs. denatured conditions expose different epitopes

  • Consider using multiple antibodies targeting different epitopes

When troubleshooting, systematically change one variable at a time and maintain detailed records of all modifications to protocols.

How can QCR6 antibodies be optimized for different respiratory complex isolation techniques?

Different experimental approaches require specific optimization of QCR6 antibody usage:

• Blue Native PAGE analysis:

  • Pre-clear samples with non-specific IgG

  • Use antibodies confirmed to recognize native conformations

  • Consider mild detergents (digitonin) to preserve supercomplex integrity

  • Validate against known complex sizes

• Supercomplex immunoprecipitation:

  • Covalently cross-link antibodies to beads to prevent contamination

  • Use mild solubilization conditions (0.5-1% digitonin)

  • Include cardiolipin in buffers to stabilize interactions

  • Elute under native conditions if functional studies are planned

• Cryo-EM sample preparation:

  • Use Fab fragments rather than whole antibodies

  • Target specific domains to facilitate orientation determination

  • Validate antibody binding doesn't disrupt complex structure

• Proximity labeling approaches:

  • Confirm that antibody binding doesn't block relevant interactions

  • Use monovalent antibody formats to prevent artificial clustering

  • Optimize enzyme fusion to maintain QCR6 function

How are QCR6 antibodies used to investigate mitochondrial dysfunction in disease?

QCR6 antibodies provide valuable tools for investigating mitochondrial dysfunction in various disease contexts:

• Respiratory chain deficiencies:

  • Quantification of QCR6 levels relative to other complex III components

  • Assessment of complex assembly using blue native electrophoresis followed by QCR6 immunodetection

  • Correlation of QCR6 integrity with disease severity markers

• Neurodegenerative diseases:

  • Examination of QCR6 post-translational modifications in affected tissues

  • Co-localization studies with markers of mitochondrial stress

  • Evaluation of QCR6-cytochrome c interactions in models of apoptosis

• Metabolic disorders:

  • Analysis of QCR6-cardiolipin interactions in diabetic models

  • Quantification of QCR6 in tissues with altered metabolic demands

Recent findings have highlighted members of the CX9C motif-carrying protein family (to which QCR6 bears structural similarity) as potential therapeutic targets in various human disorders . Disease-associated mutations in these proteins underscore their clinical relevance and the importance of specific antibody tools for their study.

What protocols enable quantitative analysis of QCR6 in tissue samples?

For accurate quantification of QCR6 in tissue samples:

• Sample preparation standardization:

  • Consistent homogenization protocols

  • Precise protein determination methods

  • Use of internal reference standards

• Quantitative Western blotting:

  • Serial dilutions of recombinant QCR6 standards

  • Infrared fluorescence detection for wider linear range

  • Normalization to multiple housekeeping proteins

  • Use of software for densitometric analysis

• ELISA development:

  • Sandwich ELISA with capture/detection antibody pairs

  • Four-parameter logistic curve fitting for standard curves

  • Validation in multiple tissue types with known QCR6 expression differences

• Mass spectrometry-based approaches:

  • Selected reaction monitoring (SRM) using QCR6-specific peptides

  • Absolute quantification using isotope-labeled standards

  • Immunoprecipitation with QCR6 antibodies followed by MS analysis

When quantifying QCR6 in tissues, researchers should be aware that mitochondrial content varies significantly between tissue types, necessitating normalization to mitochondrial markers rather than total cellular protein for meaningful comparisons.

How might QCR6 antibodies contribute to understanding supercomplex dynamics?

Emerging research opportunities using QCR6 antibodies to elucidate supercomplex dynamics include:

• Time-resolved structural studies:

  • Single-particle tracking using QCR6 antibody fragments

  • Conformational antibodies that recognize specific functional states

  • Correlation of structural changes with electron transport activity

• Supercomplex assembly investigations:

  • QCR6 antibodies to monitor incorporation into complexes during biogenesis

  • Investigation of assembly intermediates in different physiological conditions

  • Analysis of how QCR6-lipid interactions influence supercomplex stability

• Metabolic adaptation:

  • Monitoring QCR6 incorporation into supercomplexes during metabolic shifts

  • Correlation with respiratory efficiency measurements

The research observations that ΔQCR6 affects cytochrome c residence time on supercomplex regions close to electron-transferring cofactors suggests that QCR6 antibodies could be valuable tools for temporal studies of electron transport dynamics. Additionally, the finding that ΔQCR6 alters transition rates of cytochrome c from bulk solution to the complex surface opens avenues for investigating the kinetic aspects of respiratory chain function using QCR6-specific reagents.

What novel antibody-based approaches could enhance QCR6 research?

Advanced antibody technologies offer new possibilities for QCR6 research:

• Nanobodies and single-domain antibodies:

  • Smaller size allows access to sterically hindered epitopes

  • Generation of conformation-specific binders

  • Direct expression within cells for live-cell studies

• Proximity labeling antibody conjugates:

  • TurboID or APEX2 conjugated to QCR6 antibodies

  • Mapping protein neighborhoods in intact mitochondria

  • Temporal control of labeling to capture dynamic interactions

• Intrabodies:

  • Expression of QCR6-targeting antibody fragments within cells

  • Monitoring QCR6 dynamics in living systems

  • Potential for conditional interference with function

• Antibody-directed chemical biology:

  • PROTAC approaches targeting QCR6 for controlled degradation

  • Click chemistry reactions directed by QCR6 antibodies

  • Photo-crosslinking antibody conjugates to capture transient interactions

These approaches could help resolve outstanding questions about the conformationally transient N-terminal region of QCR6, which has not been structurally resolved even in high-resolution supercomplex models , potentially revealing new functional insights.